ADVIN GLOBAL, a company that developed and patented the VRNOW simulator for the rehabilitation of military and civilian patients suffering from phantom pain and musculoskeletal disorders, has implemented its product in several Ukrainian medical institutions and is preparing to scale to the European market.
ADVIN GLOBAL claims to be the first Ukrainian IT company that not only adapted existing technologies but also "developed a completely new solution from scratch" and has gone through the full cycle from concept to certified medical product VRNOW, obtaining a patent.
"We saw that Ukraine has all the opportunities to become not just a consumer, but also a developer of world-class medical technologies. Our experience has proven that Ukrainian specialists are capable of creating innovative products that meet international standards," said Artem Chyhyrynskyi, CEO of ADVIN GLOBAL, during his speech at the 2025 World Economic Forum in Davos.
In 2024, the company received Ukraine Patent No. 158352 for its VR technology used in the rehabilitation of patients with phantom pain. This is one of the first IP cases for the MedTech product market in Ukraine. The patent protects a unique algorithm for the patient's interaction with the virtual environment, which accurately reproduces the movements of a missing limb based on signals from preserved muscles. This technology uses neuroplasticity principles to reprogram the brain and reduce phantom pain, as well as improve prosthetic control.
"Our patent is not just legal protection for the idea, it’s recognition of the uniqueness and innovation of our approach. This is the first case in Ukraine where an IT company received a patent for VR technology in medical rehabilitation, which opens doors to international markets," said Valerii Soroka, Product Manager.
In the last six months, the VRNOW simulator has been implemented in seven leading medical institutions in Ukraine, including hospitals treating military personnel and children's hospitals, such as "Okhmatdyt." More than 500 patients have undergone rehabilitation courses using this VR simulator. ADVIN GLOBAL claims that over 40 leading medical centers in the country, including "Unbroken," have expressed their intention to use the simulator for daily rehabilitation.
VRNOW operates on the principles of neuroplasticity—the brain's ability to change and form new connections. When a person in VR sees their virtual limb and can "control" it, the brain begins to respond as if that body part is truly present. This helps reduce phantom pain, restore motor function, reduce anxiety levels, and accelerate the return to active life.
ADVIN GLOBAL has already started the process of certifying VRNOW according to European standards for entry into the EU market. According to expert estimates, the European rehabilitation technology market is growing, and VR solutions in this context are potentially effective but still underdeveloped in the market. The company believes this gives the Ukrainian-made product a chance to occupy high positions in the MedTech market.
